Livongo Health, Inc.

If you purchased Livongo Health, Inc. securities and would like to join the action, please click "Join This Action" below.

LIVONGO MERGER INVESTIGATION: HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE SALE OF LIVONGO HEALTH, INC. IS FAIR TO SHAREHOLDERS; INVESTORS ARE ENCOURAGED TO CONTACT THE FIRM

August 5, 2020.

New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Livongo Health, Inc. (NASDAQ: LVGO) to Teladoc Health, Inc. is fair to Livongo shareholders. Under the terms of the agreement, each Livongo share will be exchanged for 0.5920x shares of Teladoc plus cash consideration of $11.33 for each Livongo share. On behalf of Livongo shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.

The investigation concerns whether Livongo and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: (1) obtain the best possible consideration for Livongo shareholders; (2) determine whether Teladoc is underpaying for Livongo; and (3) disclose all material information necessary for Livongo shareholders to adequately assess and value the proposed transaction.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Certification

Scroll to Top